Bank of New York Mellon Corp Purchases Shares of 232,666 Anteris Technologies Global Corp. $AVR

Key Points

• Bank of New York Mellon acquired 232,666 shares of Anteris Technologies Global, worth approximately $2.29 million, giving it a 0.24% stake.
• Analyst sentiment is generally positive: four analysts rate the stock Buy and one rates it Sell, producing a “Moderate Buy” consensus and an average price target of $16 versus the reported $9.04 share price.
• Anteris reported a quarterly loss of $0.30 per share, worse than the $0.21 consensus estimate, while revenue of $1.01 million also missed expectations; insiders have sold about $25.2 million of stock over the past three months.

Bank of New York Mellon Corp acquired a new position in Anteris Technologies Global Corp. (NASDAQ:AVR - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 232,666 shares of the company's stock, valued at approximately $2,292,000. Bank of New York Mellon Corp owned about 0.24% of Anteris Technologies Global as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in AVR. L1 Capital Pty Ltd raised its stake in shares of Anteris Technologies Global by 143.2% in the third quarter. L1 Capital Pty Ltd now owns 6,838,136 shares of the company's stock valued at $30,772,000 after acquiring an additional 4,026,136 shares in the last quarter. ADAR1 Capital Management LLC lifted its stake in Anteris Technologies Global by 205.9% during the first quarter. ADAR1 Capital Management LLC now owns 3,789,132 shares of the company's stock worth $21,030,000 after purchasing an additional 2,550,355 shares during the last quarter. Perceptive Advisors LLC lifted its position in shares of Anteris Technologies Global by 104.4% during the 1st quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company's stock worth $19,011,000 after buying an additional 1,750,000 shares during the last quarter. Nantahala Capital Management LLC grew its holdings in shares of Anteris Technologies Global by 31.9% during the fourth quarter. Nantahala Capital Management LLC now owns 2,530,910 shares of the company's stock worth $12,629,000 after purchasing an additional 612,244 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in shares of Anteris Technologies Global by 32.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,417,627 shares of the company's stock valued at $6,379,000 after purchasing an additional 349,299 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Weiss Ratings restated a "sell (d-)" rating on shares of Anteris Technologies Global in a research note on Wednesday, August 26th. Cantor Fitzgerald restated an "overweight" rating and set a $15.00 price objective on shares of Anteris Technologies Global in a research report on Friday, August 14th. Barclays raised their target price on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the stock an "overweight" rating in a research note on Friday, May 15th. Finally, Wall Street Zen upgraded shares of Anteris Technologies Global from a "sell" rating to a "hold" rating in a research report on Saturday, May 16th. Four investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $16.00.

Anteris Technologies Global Price Performance

AVR opened at $9.04 on Tuesday. Anteris Technologies Global Corp. has a 12 month low of $3.30 and a 12 month high of $11.06. The business has a 50-day moving average of $8.93 and a two-hundred day moving average of $7.75. The stock has a market capitalization of $881.04 million, a price-to-earnings ratio of -4.64 and a beta of 1.80.

Anteris Technologies Global (NASDAQ:AVR - Get Free Report) last released its earnings results on Tuesday, August 11th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.09). Anteris Technologies Global had a negative return on equity of 77.69% and a negative net margin of 4,619.27%.The company had revenue of $1.01 million during the quarter, compared to analyst estimates of $1.50 million. During the same period in the prior year, the business posted ($0.58) earnings per share. Equities research analysts anticipate that Anteris Technologies Global Corp. will post -1.21 earnings per share for the current year.

Insider Buying and Selling at Anteris Technologies Global

In other news, major shareholder L1 Capital Pty Ltd sold 7,800 shares of the firm's stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $8.83, for a total transaction of $68,874.00. Following the completion of the sale, the insider owned 4,803,541 shares of the company's stock, valued at approximately $42,415,267.03. This trade represents a 0.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have sold a total of 3,008,459 shares of company stock worth $25,243,576 over the last three months. 4.50% of the stock is currently owned by company insiders.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Want to see what other hedge funds are holding AVR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anteris Technologies Global Corp. (NASDAQ:AVR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.